BioNTech Newsroom

BioNTech Is Maintained at Hold by TD Cowen

Dow Jones01:50

A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $110 to $145

Futu NewsNov 6 21:08

Promising Developments in BioNTech's Oncology Pipeline Drive Buy Rating

TipRanksNov 6 16:21

BioNTech Price Target Cut to $122.00/Share From $132.00 by TD Cowen

Dow JonesNov 6 03:04

A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $122 to $171

Futu NewsNov 5 21:08

BioNTech SE (BNTX) Receives a Hold From Oppenheimer

TipRanksNov 5 20:59

Deutsche Bank Sticks to Their Buy Rating for BioNTech SE (BNTX)

TipRanksNov 5 19:42

BioNTech SE: Strong Financial Performance and Promising Future Justify Buy Rating

TipRanksNov 5 19:28

BioNTech Is Maintained at Neutral by JP Morgan

Dow JonesNov 4 22:50

BioNTech Analyst Ratings

BenzingaNov 4 22:40

Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX)

TipRanksNov 4 21:09

CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $171

Futu NewsOct 31 21:40

Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145

Futu NewsOct 28 21:34

BioNTech Is Maintained at Hold by TD Cowen

Dow JonesOct 21 22:22

BioNTech Analyst Ratings

BenzingaOct 21 22:12

Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145

Futu NewsOct 21 21:35

TD Cowen Maintains BioNTech(BNTX.US) With Hold Rating, Raises Target Price to $132

Futu NewsOct 21 19:31

Cautious Long-term Growth Potential: Yaron Werber's Hold Rating on BioNTech SE

TipRanksOct 21 18:57

Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145

Futu NewsOct 18 23:31

Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145

Futu NewsOct 14 21:31